Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 69 of 1714:
59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, L type, alpha 1D subunit SIMVASTATIN Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit SIMVASTATIN Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SIMVASTATIN Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit SIMVASTATIN Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit SIMVASTATIN Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit SIMVASTATIN Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SIMVASTATIN Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
phosphodiesterase 3B LIPOPOLYSACCHARIDE E. COLI O55:B5 Phosphodiesterase PDE3 48% NoneNone NoneNone View
phosphodiesterase 3A LIPOPOLYSACCHARIDE E. COLI O55:B5 Phosphodiesterase PDE3 48% NoneNone NoneNone View
Sigma-2 Receptor PROGESTERONE Sigma2 48% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C ALPHA-NAPHTHOFLAVONE Serotonin 5-HT2C 48% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) 3-METHYLCHOLANTHRENE Protein Tyrosine Kinase, HER2 Receptor 48% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, theta ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase ITRACONAZOLE CYP450-1A2 Inhibition 45% NoneNone NoneNone View
matrix metallopeptidase 9 L-744832 Protease, Matrix Metalloprotease-9 (MMP-9) 45% NoneNone NoneNone View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) L-744832 Protease, Matrix Metalloprotease-9 (MMP-9) 45% NoneNone NoneNone View
adrenergic receptor, alpha 2a IMIQUIMOD Imidazoline I2, Central 45% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) IMIQUIMOD Imidazoline I2, Central 45% NoneNone NoneNone View
thromboxane A synthase 1 L-744832 Thromboxane Synthetase 45% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) L-744832 Thromboxane Synthetase 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel associated protein 1 GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel associated protein 2 GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta GW-1929 Sodium Channel, Site 2 45% NoneNone NoneNone View
adrenergic receptor, alpha 2a ECONAZOLE Imidazoline I2, Central 45% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) ECONAZOLE Imidazoline I2, Central 45% NoneNone NoneNone View
matrix metallopeptidase 9 MICONAZOLE Protease, Matrix Metalloprotease-9 (MMP-9) 45% NoneNone NoneNone View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) MICONAZOLE Protease, Matrix Metalloprotease-9 (MMP-9) 45% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase BUTAMBEN CYP450-2C19 Inhibition 45% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase CISAPRIDE CYP450-2C19 Inhibition 45% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) FENOFIBRATE Adrenergic alpha1D 45% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 CIGLITAZONE Serotonin 5-HT6 45% NoneNone NoneNone View
melanocortin 4 receptor CIGLITAZONE Melanocortin MC4 45% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 DIETHYLSTILBESTROL Muscarinic M4 45% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) DIETHYLSTILBESTROL Protein Tyrosine Kinase, Lck 45% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 FLUTAMIDE Cyclooxygenase COX-1 45% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) FLUTAMIDE Cyclooxygenase COX-1 45% NoneNone NoneNone View
mitogen activated protein kinase 1 PYROGALLOL Protein Serine/Threonine Kinase, ERK2 45% NoneNone NoneNone View
mitogen-activated protein kinase 1 PYROGALLOL Protein Serine/Threonine Kinase, ERK2 45% NoneNone NoneNone View
dopamine receptor D3 TOLNAFTATE Dopamine D3 48% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) MEBENDAZOLE Protein Tyrosine Kinase, Lck 48% NoneNone NoneNone View
opioid receptor, kappa 1 HALOPERIDOL Opiate kappa 48% NoneNone NoneNone View
matrix metalloproteinase 1 (interstitial collagenase) TRIAMTERENE Protease, Matrix Metalloprotease-1 (MMP-1) 48% NoneNone NoneNone View
Sigma-2 Receptor GENTIAN VIOLET Sigma2 48% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B IRSOGLADINE MALEATE Serotonin 5-HT2B 48% NoneNone NoneNone View
chemokine (C-C motif) receptor 5 CISPLATIN Chemokine CCR5 48% NoneNone NoneNone View
histamine receptor H 2 CITALOPRAM Histamine H2 48% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific METHYLPREDNISOLONE Phosphodiesterase PDE4 48% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific METHYLPREDNISOLONE Phosphodiesterase PDE4 48% NoneNone NoneNone View
phosphodiesterase 4D METHYLPREDNISOLONE Phosphodiesterase PDE4 48% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific METHYLPREDNISOLONE Phosphodiesterase PDE4 48% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase OXYBUTYNIN CYP450-1A2 Inhibition 48% NoneNone NoneNone View
chemokine (C-C motif) receptor 5 LOPERAMIDE Chemokine CCR5 48% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 LOPERAMIDE Dopamine Transporter 48% NoneNone NoneNone View
adrenergic receptor, alpha 2a LOPERAMIDE Imidazoline I2, Central 48% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) LOPERAMIDE Imidazoline I2, Central 48% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Serotonin 5-HT6 48% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase ETODOLAC CYP450-1A2 Inhibition 48% NoneNone NoneNone View
tachykinin receptor 2 MITOTANE Tachykinin NK2 48% NoneNone NoneNone View
adrenergic receptor, beta 3 MITOTANE Adrenergic beta3 48% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B RISPERIDONE Serotonin 5-HT4 48% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 RISPERIDONE Serotonin 5-HT4 48% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) ITRACONAZOLE Protein Tyrosine Kinase, Lck 48% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B QUINACRINE Serotonin 5-HT4 48% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 QUINACRINE Serotonin 5-HT4 48% NoneNone NoneNone View
mitogen activated protein kinase 1 NADOLOL Protein Serine/Threonine Kinase, ERK2 48% NoneNone NoneNone View
mitogen-activated protein kinase 1 NADOLOL Protein Serine/Threonine Kinase, ERK2 48% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit RITONAVIR Calcium Channel Type L, Benzothiazepine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 CYPROTERONE ACETATE Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit TERBINAFINE Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit TERBINAFINE Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TERBINAFINE Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit TERBINAFINE Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit TERBINAFINE Calcium Channel Type L, Phenylalkylamine 48% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 2 ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 2 ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 1 ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, delta ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 ALPHA-NAPHTHOFLAVONE GABAA, Benzodiazepine, Central 47% NoneNone NoneNone View
opioid receptor, sigma 1 BW-723C86 Sigma1 47% NoneNone NoneNone View
mu-opioid receptor MOR TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Opiate mu 47% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase TRANS-PLATINUM(II)DIAMMINE DICHLORIDE CYP450-1A2 Inhibition 47% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 3,3',5-TRIIODO-L-THYRONINE Serotonin 5-HT6 47% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase AMBROXOL CYP450-2C19 Inhibition 47% NoneNone NoneNone View
tachykinin receptor 2 FLUNARIZINE Tachykinin NK2 47% NoneNone NoneNone View
mitogen activated protein kinase 14 GLYCYRRHIZIN Protein Serine/Threonine Kinase, p38alpha 47% NoneNone NoneNone View
mitogen-activated protein kinase 14 GLYCYRRHIZIN Protein Serine/Threonine Kinase, p38alpha 47% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific MONTELUKAST Phosphodiesterase PDE4 47% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific MONTELUKAST Phosphodiesterase PDE4 47% NoneNone NoneNone View
phosphodiesterase 4D MONTELUKAST Phosphodiesterase PDE4 47% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific MONTELUKAST Phosphodiesterase PDE4 47% NoneNone NoneNone View
dopamine receptor D4 FLUNARIZINE Dopamine D4.2 47% NoneNone NoneNone View
chemokine (C-C motif) receptor 5 VINDESINE Chemokine CCR5 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Benzothiazepine 47% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 AMITRAZ CYP450-3A4 Inhibition 47% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase ONDANSETRON CYP450-2D6 Inhibition 47% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase FLAVOXATE CYP450-2D6 Inhibition 47% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta CETYLPYRIDINIUM BROMIDE Sodium Channel, Site 2 46% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase BETA-ESTRADIOL 3-BENZOATE CYP450-2C19 Inhibition 45% NoneNone NoneNone View
thromboxane A synthase 1 RAPAMYCIN Thromboxane Synthetase 45% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) RAPAMYCIN Thromboxane Synthetase 45% NoneNone NoneNone View
phosphodiesterase 3B ALPHA-NAPHTHOFLAVONE Phosphodiesterase PDE3 45% NoneNone NoneNone View
phosphodiesterase 3A ALPHA-NAPHTHOFLAVONE Phosphodiesterase PDE3 45% NoneNone NoneNone View
chemokine (C-C motif) receptor 2 3-METHYLCHOLANTHRENE Chemokine CCR2B 45% NoneNone NoneNone View
adenosine A1 receptor 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Adenosine A1 45% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 AMOXAPINE Dopamine Transporter 45% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 AMOBARBITAL Cyclooxygenase COX-2 45% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) AMOBARBITAL Cyclooxygenase COX-2 45% NoneNone NoneNone View
adrenergic receptor, alpha 1b AMIODARONE Adrenergic alpha1B 45% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 METHIMAZOLE Cyclooxygenase COX-1 45% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) METHIMAZOLE Cyclooxygenase COX-1 45% NoneNone NoneNone View
acetylcholinesterase (YT blood group) ERGOTAMINE Acetylcholinesterase 45% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase ERGOTAMINE Acetylcholinesterase 45% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 QUETIAPINE Sodium Channel, Site 2 45% NoneNone NoneNone View